Treatment Parameter | Control | TAA | TAA + NA | TAA + VB2 | TAA + VC | TAA + NA,VB2,VC |
---|---|---|---|---|---|---|
AST(U/l) | 46.53 ± 1.08 | 269.36 ± 11.75a | 137.64 ± 6.83a,b | 142.43 ± 7.76a,b | 170.34 ± 7.33a,b | 95.17 ± 4.59a,b,c |
ALT(U/l) | 23.17 ± 1.34 | 153.46 ± 8.63a | 114.56 ± 4.78a,b | 109.89 ± 9.32a,b | 94.57 ± 3.21a,b | 65.46 ± 1.96a,b,c |
ALP(U/l) | 150.46 ± 10.06 | 676.35 ± 21.67a | 470.48 ± 26.41a,b | 418.34 ± 15.68a,b | 580.41 ± 19.73a,b | 242.00 ± 15.47a,b,c |
LDH | 212.55 ± 8.69 | 802.40 ± 4.75a | 512.07 ± 18.67a,b | 450.82 ± 14.25a,b | 478.16 ± 17.56a,b | 275.44 ± 12.49a,b,c |
Total bilirubin(mg/dl) | 0.43 ± 0.01 | 0.91 ± 0.03a | 0.63 ± 0.01a,b | 0.70 ± 0.04a,b | 0.66 ± 0.03a,b | 0.54 ± 0.02a,b,c |
Total protein(g/dl) | 7.34 ± 1.58 | 5.27 ± 0.10a | 5.88 ± 0.19a,b | 6.09 ± 0.27a,b | 6.47 ± 0.34a,b | 7.55 ± 0.10a,b,c |